Overview

EWO1 in Persistent Allergic Rhinitis Patients

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The aim of this double-blind, randomized, parallel group, placebo-controlled study is to assess the efficacy and safety of EWO1 in patients with moderate to severe perennial allergic rhinitis (AR).

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

China Medical University Hospital